Sweden’s largest biotech magazine, Biotech Sweden, has declared the new center in Oslo as Europe’s largest investment in cancer research.  According to Biotech Sweden, ”the Oslo Cancer Cluster, OCC, is a research and industry cluster focused on treatments and diagnostics of cancer. Today the cluster consists of over 40 members, including research institutions, life science companies, patient organizations and a university hospital.”

Bjarte Reve, CEO of the Oslo Cancer Cluster, says: ”Cooperation and transfer of knowledge between different actors is very important for a cluster. The best way to transfer knowledge is through personal meetings, so it is very important to have everyone gathered at the same place.”

Plans for the new center include a college dedicated to medicine, biotechnology, innovation and entreprenueurship. ”By integrating education into the science park we hope to secure the recruitment of well-trained talent, and thereby secure the long-term quality of research conducted here,” Reve concludes.  

See the entire article at Biotech Sweden